Versameb
Versameb is a biopharmaceutical company.
Versameb has raised €16M across 3 funding rounds, most recently a Seed round in Jul 2020. Based in Allschwil, Switzerland; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€16,149,853
Funding rounds
3
Investors
0
distinct backers
Active since
2018-12
latest 2020-07
Funding by year
EUR raised per yearVersameb — funding by year — interactive chart.
Data table
| Versameb — funding by year | |
|---|---|
| 2018 | €4.7M |
| 2019 | €5.9M |
| 2020 | €5.6M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-16 | Seed | €5.6M | — | View deal → |
| 2019-10-01 | Seed | €5.9M | — | View deal → |
| 2018-12-27 | Seed | €4.7M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData